C-src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton

Molecular and Cellular Biology

Volumn 32, Issue 14, 2012, Pages 2943-2953

  Izawa, Takashi ^a   Zou, Wei ^a   Chappel, Jean C ^a   Ashley, Jason W ^b   Feng, Xu ^b   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE P60; PROTEIN SH3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; VITRONECTIN RECEPTOR;

ACTIN FILAMENT; ARTICLE; BINDING KINETICS; BONE MARROW CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOSKELETON; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; SIGNAL TRANSDUCTION; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; BONE RESORPTION; CYTOSKELETON; INTEGRIN ALPHAVBETA3; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; MUTAGENESIS; OSTEOCLASTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-TYROSINE KINASES; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SRC HOMOLOGY DOMAINS;

EID: 84863991650     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00077-12     Document Type: Article

References (30)

1. Arias-Salgado EG, et al. 2003. Src kinase activation by direct interaction with the integrin b cytoplasmic domain. Proc. Natl. Acad. Sci. U. S. A. 100:13298-13302.
2. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1622-1627.
3. Burgess TL, et al. 1999. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145:527-538.
4. Chan B, et al. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5:155-160.
5. Chellaiah M, Fitzgerald C, Alvarez U, Hruska K. 1998. c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase. J. Biol. Chem. 273:11908-11916.
6. Croke M, et al. 2011. Rac deletion in osteoclasts causes severe osteopetrosis. J. Cell Sci. 124:3811-3821.
7. Destaing O, et al. 2008. The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol. Biol. Cell 19:394-404.
8. Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL. 2003. c-Fms and the avb3 integrin collaborate during osteoclast differentiation. J. Clin. Invest. 111:749-758.
9. Faccio R, et al. 2005. Vav3 regulates osteoclast function and bone mass. Nat. Med. 11:284-290.
10. Faccio R, Zou W, Colaianni G, Teitelbaum SL, Ross FP. 2003. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype. J. Cell. Biochem. 90:871-883.
11. Feng X, et al. 2001. A Glanzmann's mutation in b3 integrin specifically impairs osteoclast function. J. Clin. Invest. 107:1137-1144.
12. Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K. 2000. Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141:2129-2138.
13. Kim HJ, et al. 2006. Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116:2152-2160.
14. Lam J, et al. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488.
15. Li L, et al. 2007. Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc. Natl. Acad. Sci. U. S. A. 104:16468-16473.
16. Liu W, et al. 2004. Functional identification of three receptor activator of NF-κB cytoplasmic motifs mediating osteoclast differentiation and function. J. Biol. Chem. 279:54759-54769.
17. Macdonald JL, Pike LJ. 2005. A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46:1061-1067.
18. McHugh KP, et al. 2000. Mice lacking b3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105:433-440.
19. Miyazaki T, et al. 2004. Src kinase activity is essential for osteoclast function. J. Biol. Chem. 279:17660-17666.
20. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
21. Patwardhan P, Resh MD. 2010. Myristoylation and membrane binding regulate c-Src stability and kinase activity. Mol. Cell. Biol. 30:4094-4107.
22. Reeve JL, et al. 2009. SLP-76 couples Syk to the osteoclast cytoskeleton. J. Immunol. 183:1804-1812.
23. Schwartzberg PL, et al. 1997. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. Genes Dev. 11:2835-2844.
24. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
25. Teitelbaum SL. 2007. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170:427-435.
26. Wong BR, et al. 1999. TRANCE, a TNF family member, activates Akt/ PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4:1041-1049.
27. Xing L, et al. 2001. Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev. 15:241-253.
28. Xu D, et al. 2004. Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. Biochem. J. 383:219-225.
29. Zou W, et al. 2007. Syk, c-Src, the avb3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176: 877-888.
30. Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol. Cell 31:422-431.